Classification of morphea (localized scleroderma)
暂无分享,去创建一个
[1] P. Duray,et al. Identification of Borrelia burgdorferi in diffuse fasciitis with peripheral eosinophilia: borrelial fasciitis. , 1994, JAMA.
[2] M. Fujimoto,et al. Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma. , 1994, Journal of the American Academy of Dermatology.
[3] M. Fujimoto,et al. Demonstration of interleukin 8 in serum samples of patients with localized scleroderma. , 1994, Archives of dermatology.
[4] J. Roujeau,et al. Internal Involvement in Localized Scleroderma , 1994, Medicine.
[5] K. Welsh,et al. Genetics of scleroderma. , 1994, Clinics in dermatology.
[6] A. Janin,et al. Fasciitis in Chronic Graft-versus-Host Disease: A Clinicopathologic Study of 14 Cases , 1994, Annals of Internal Medicine.
[7] W. Su,et al. Bullous morphea: clinical, pathologic, and immunopathologic evaluation of thirteen cases. , 1994, Journal of the American Academy of Dermatology.
[8] E. Silverman,et al. Serum levels of soluble interleukin-2 receptor. A marker of disease activity in localized scleroderma. , 1994, Arthritis and rheumatism.
[9] E. Silverman,et al. Localized scleroderma in childhood: a report of 30 cases. , 1994, Seminars in arthritis and rheumatism.
[10] M. Pennesi,et al. Localized scleroderma after infection with Epstein-Barr virus. , 1993, Clinical and experimental rheumatology.
[11] H. Ihn,et al. Antihistone antibodies in patients with localized scleroderma. , 1993, Arthritis and rheumatism.
[12] D. Murrell. A radical proposal for the pathogenesis of scleroderma. , 1993, Journal of the American Academy of Dermatology.
[13] K. Takehara,et al. Coexistence of morphea and systemic sclerosis. , 1993, Dermatology.
[14] T. Lehman. The Parry Romberg syndrome of progressive facial hemiatrophy and linear scleroderma en coup de sabre. Mistaken diagnosis or overlapping conditions? , 1992, The Journal of rheumatology.
[15] B. Krafchik. Localized cutaneous scleroderma. , 1992, Seminars in dermatology.
[16] C. Fink,et al. Intracranial findings in progressive facial hemiatrophy. , 1992, The Journal of rheumatology.
[17] J. DeLozier,et al. Facial reconstruction consideration in rheumatic diseases. , 1991, Rheumatic diseases clinics of North America.
[18] R. Davidson,et al. Osteolysis of the calcaneus in a child with localized scleroderma. , 1991, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.
[19] K. Toda,et al. Lichen sclerosus et atrophicus, morphea, and coexistence of both diseases. Histological studies using lectins. , 1991, Archives of dermatology.
[20] J. Weiss. Antimalarial medications in dermatology. A review. , 1991, Dermatologic clinics.
[21] K. Harii,et al. Repair of "coup de sabre" with tissue expander. , 1991, British Journal of Plastic Surgery.
[22] G. Stanek,et al. Borrelia burgdorferi and different types of morphea. , 1991, Dermatologica.
[23] A. N. Mayeno,et al. Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome. , 1990, Science.
[24] M. Suttorp-Schulten,et al. Linear scleroderma associated with ptosis and motility disorders. , 1990, The British journal of ophthalmology.
[25] R. Pereira,et al. Childhood linear scleroderma "en coup de sabre" with uveitis. , 1990, The Journal of pediatrics.
[26] T. Medsger,et al. D-penicillamine in the treatment of localized scleroderma. , 1990, Archives of dermatology.
[27] E. Sternberg,et al. Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. , 1990, The New England journal of medicine.
[28] S. Jimenez,et al. Evaluation of transforming growth factor beta and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization. , 1990, The Journal of investigative dermatology.
[29] Littman Bh. Linear scleroderma: a response to neurologic injury? Report and literature review. , 1989 .
[30] I. Dunsmore,et al. An investigation into the incidence of auto‐immune disorders in patients with localized morphoea , 1989, The British journal of dermatology.
[31] N. Smith,et al. Solitary morphoea profunda , 1989, The British journal of dermatology.
[32] F. Wollheim,et al. Treatment of systemic sclerosis in 1988. , 1989, Seminars in arthritis and rheumatism.
[33] M. Bagot,et al. Borrelia burgdorferi and localized scleroderma. , 1989, Archives of dermatology.
[34] A. Silman,et al. An epidemiological study of scleroderma in the West Midlands. , 1988, British journal of rheumatology.
[35] L. Dabich,et al. Retrospective studies in scleroderma: skin response to potassium para-aminobenzoate therapy. , 1988, Clinical and experimental rheumatology.
[36] C. Michet,et al. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. , 1988, Seminars in arthritis and rheumatism.
[37] E. Vuorio,et al. Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization. , 1988, The Journal of investigative dermatology.
[38] J. Heino,et al. Interferon-α and interferon-γ reduce excessive collagen synthesis and procollagen mRNA levels of scleroderma fibroblasts in culture , 1988 .
[39] G. Stanek,et al. Histological evidence for spirochetal origin of morphea and lichen sclerosus et atrophicans. , 1987, The American Journal of dermatopathology.
[40] G. Stanek,et al. Evidence for spirochetal origin of circumscribed scleroderma (morphea). , 1987, Acta dermato-venereologica.
[41] É. Török,et al. Morphoea in children , 1986, Clinical and experimental dermatology.
[42] R. Tang,et al. Pseudo oculomotor palsy as the presenting sign of linear scleroderma. , 1986, Journal of pediatric ophthalmology and strabismus.
[43] T. Medsger,et al. Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. , 1986, Annals of internal medicine.
[44] W. P. Su,et al. Bullous morphea profunda. , 1986, The American Journal of dermatopathology.
[45] B. Singsen,et al. Scleroderma in childhood. , 1977, Pediatric clinics of North America.
[46] R. Cormane,et al. Hereditary deficiency of C2 in association with linear scleroderma 'en coup de sabre'. , 1986, Archives of dermatology.
[47] P. Fritsch,et al. Treatment of localized scleroderma and lichen sclerosus with etretinate. , 1984, Acta dermato-venereologica.
[48] Y. Moroi,et al. Antinuclear antibodies in localized scleroderma. , 1983, Arthritis and rheumatism.
[49] R. Grahame,et al. Cyclofenil treatment of scleroderma--a controlled study. , 1983, British journal of rheumatology.
[50] H. Perry. DISEASES THAT PRESENT AS CUTANEOUS SCLEROSIS * , 1982, The Australasian journal of dermatology.
[51] R. Winkelmann,et al. Carpal tunnel syndrome in cutaneous connective tissue disease: generalized morphea, lichen sclerosus, fasciitis, discoid lupus erythematosus, and lupus panniculitis. , 1982, Journal of the American Academy of Dermatology.
[52] S. Mizel,et al. Interleukin 1, a potential regulator of fibroblast proliferation. , 1982, Journal of immunology.
[53] J. R. Person,et al. Morphea profunda. A new concept and a histopathologic study of 23 cases. , 1981 .
[54] C. Michet,et al. Eosinophilic fasciitis: report of 15 cases. , 1981, Mayo Clinic proceedings.
[55] E. Barnes,et al. Collagen accumulation by dermal fibroblast cultures of patients with linear localized scleroderma. , 1980, The Journal of rheumatology.
[56] R. Winkelmann,et al. Disabling pansclerotic morphea of children. , 1980, Archives of dermatology.
[57] C. He,et al. Eosinophilic fasciitis (Shulman syndrome) in association with morphoea and systemic sclerosis. , 1980 .
[58] D. Alarcón-Segovia,et al. Long-term evaluation of colchicine in the treatment of scleroderma. , 1979, The Journal of rheumatology.
[59] M. Jarratt,et al. Eosinophilic fasciitis: an early variant of scleroderma. , 1979, Journal of the American Academy of Dermatology.
[60] W. Su,et al. Subcutaneous morphoea: a clinical study of sixteen cases , 1979, The British journal of dermatology.
[61] Neldner Kh. Treatment of localized linear scleroderma with phenytoin. , 1978 .
[62] R. Winkelmann,et al. Concurrent localized scleroderma and discoid lupus erythematosus. Cutaneous 'mixed' or 'overlap' syndrome. , 1978, Archives of dermatology.
[63] S. Ayres,et al. Is vitamin E involved in the autoimmune mechanism? , 1978, Cutis.
[64] R. Fleischmajer,et al. Failure of dimethyl sulfoxide in the treatment of scleroderma. , 1977, Archives of dermatology.
[65] S. Jabłońska. Scleroderma and pseudoscleroderma , 1975 .
[66] R. Fleischmajer,et al. Generalized morphea. I. Histology of the dermis and subcutaneous tissue. , 1972, Archives of dermatology.
[67] J. J. Dilley,et al. Bilateral linear scleroderma en coup de sabre. , 1968, Archives of dermatology.
[68] W. Honeycutt,et al. Generalized scleroderma. Treatment with an immunosuppressive agent. , 1968, Archives of dermatology.
[69] D. Tuffanelli,et al. Linear scleroderma with hemiatrophy: report of three cases associated with collagen-vascular disease. , 1966, Dermatologica.
[70] R. Winkelmann,et al. Scleroderma. An evaluation of treatment with disodium edetate. , 1962, Archives of dermatology.
[71] A. Curtis,et al. The prognosis of localized scleroderma. , 1958, A.M.A. archives of dermatology.
[72] H. Christianson,et al. Localized scleroderma; a clinical study of two hundred thirty-five cases. , 1956, A.M.A. archives of dermatology.
[73] L. Rubin. Linear scleroderma; association with abnormalities of the spine and nervous system. , 1948, Archives of dermatology and syphilology.
[74] R. Wartenberg. PROGRESSIVE FACIAL HEMIATROPHY , 1945 .
[75] P. A. O’leary,et al. A CLINICAL STUDY OF ONE HUNDRED AND THREE CASES OF SCLERODERMA , 1930 .